Literature DB >> 20832742

Hypertension in diabetic pregnancy: impact and long-term outlook.

Antonietta Colatrella1, Valentina Loguercio, Luca Mattei, Massimo Trappolini, Camilla Festa, Michela Stoppo, Angela Napoli.   

Abstract

Hypertensive disorders in pregnancy can be chronic, pregestational or just diagnosed before the 20th week, or newly diagnosed in the second half of pregnancy. Any type of hypertension is more frequent in diabetic pregnancies with a different distribution among different types of diabetes. Most of the evidence is for pre-eclampsia associated with a marked increase in primary caesarean section, preterm birth and more need for neonatal intensive care. Different risk factors and pregnancy outcomes would support the hypothesis that pre-eclampsia and gestational hypertension might be largely separate entities, but this position is not unanimously accepted. Chronic hypertension increases with age and duration of diabetes, predicting increased rates of prematurity and neonatal morbidity, especially when associated with superimposed pre-eclampsia. Long-term consequences are observed in women whose pregnancy was complicated by hypertension such as chronic hypertension and cardiovascular diseases. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20832742     DOI: 10.1016/j.beem.2010.05.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  14 in total

1.  Reproductive endocrinology: Predictive biomarkers of pre-eclampsia in women with T1DM.

Authors:  Baha M Sibai
Journal:  Nat Rev Endocrinol       Date:  2013-10-08       Impact factor: 43.330

Review 2.  Preeclampsia and diabetes.

Authors:  Tracey L Weissgerber; Lanay M Mudd
Journal:  Curr Diab Rep       Date:  2015-03       Impact factor: 4.810

3.  White's classification and pregnancy outcome in women with type 1 diabetes: a population-based cohort study.

Authors:  Miira M Klemetti; Hannele Laivuori; Minna Tikkanen; Mika Nuutila; Vilho Hiilesmaa; Kari Teramo
Journal:  Diabetologia       Date:  2016-01       Impact factor: 10.122

4.  Hypertensive disorders during pregnancy and 3 years after delivery in women with gestational hyperglycemia.

Authors:  C Festa; L Mattei; O Bitterman; B Pintaudi; M Framarino Dei Malatesta; P Bianchi; M Trappolini; A Colatrella; A Napoli
Journal:  J Endocrinol Invest       Date:  2018-01-24       Impact factor: 4.256

5.  The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes.

Authors:  Keenan E Yanit; Jonathan M Snowden; Yvonne W Cheng; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2012-08-11       Impact factor: 8.661

Review 6.  Hypertensive disorders during pregnancy and risk of type 2 diabetes in later life: a systematic review and meta-analysis.

Authors:  Zengfang Wang; Zengyan Wang; Luang Wang; Mingyue Qiu; Yangang Wang; Xu Hou; Zhong Guo; Bin Wang
Journal:  Endocrine       Date:  2016-08-12       Impact factor: 3.633

7.  Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial.

Authors:  Valerie A Holmes; Ian S Young; Christopher C Patterson; Donald W M Pearson; James D Walker; Michael J A Maresh; David R McCance
Journal:  Diabetes Care       Date:  2011-06-02       Impact factor: 19.112

8.  Does continuous glucose monitoring during pregnancy improve glycaemic and health outcomes in women with type 1 diabetes?-what the CONCEPTT trial adds.

Authors:  Diane Farrar; Matthew D Campbell
Journal:  Ann Transl Med       Date:  2018-05

9.  Comparison of Insulin Lispro Protamine Suspension with NPH Insulin in Pregnant Women with Type 2 and Gestational Diabetes Mellitus: Maternal and Perinatal Outcomes.

Authors:  Antonietta Colatrella; Natalia Visalli; Santina Abbruzzese; Sergio Leotta; Marzia Bongiovanni; Angela Napoli
Journal:  Int J Endocrinol       Date:  2013-06-10       Impact factor: 3.257

10.  Hypothyroidism and diabetes mellitus - a risky dual gestational endocrinopathy.

Authors:  Dan Tirosh; Neta Benshalom-Tirosh; Lena Novack; Fernanda Press; Ruthy Beer-Weisel; Arnon Wiznitzer; Moshe Mazor; Offer Erez
Journal:  PeerJ       Date:  2013-03-19       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.